Bioanalysis Redefined
Dash Bio is a tech-enabled services startup that was founded to disrupt the way drugs are developed. While there has been incredible innovation with hundreds of AI startups in drug discovery, nothing has fundamentally changed in development. It is dominated by ad hoc, manual, labor-intensive processes that drive up the cost and time to bring drugs to market. Dash is built to change that. Instead of the kind of labor-based CRO consulting that dominates the space today, we’re building tech-first products that leverage AI and robotics to automate and accelerate critical steps. Our first product line is clinical bioanalysis, which is the testing of samples taken from subjects in clinical trials. We’re planning for turnaround times for assay development and sample testing that are 10x faster than the industry average. Join us as we transform the industry.